Enanta Pharmaceuticals Stock Price History
ENTA Stock | USD 6.31 0.13 2.02% |
If you're considering investing in Enanta Stock, it is important to understand the factors that can impact its price. As of today, the current price of Enanta Pharmaceuticals stands at 6.31, as last reported on the 22nd of March, with the highest price reaching 6.49 and the lowest price hitting 6.21 during the day. At this point, Enanta Pharmaceuticals is relatively risky. Enanta Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0216, which denotes the company had a 0.0216 % return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Enanta Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Enanta Pharmaceuticals' Semi Deviation of 3.18, mean deviation of 3.37, and Downside Deviation of 3.38 to check if the risk estimate we provide is consistent with the expected return of 0.12%.
Enanta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Enanta |
Sharpe Ratio = 0.0216
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | ENTA | Huge Risk |
Negative Returns |
Estimated Market Risk
5.41 actual daily | 48 52% of assets are more volatile |
Expected Return
0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Enanta Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enanta Pharmaceuticals by adding it to a well-diversified portfolio.
Enanta Pharmaceuticals Stock Price History Chart
There are several ways to analyze Enanta Stock price data. The simplest method is using a basic Enanta candlestick price chart, which shows Enanta Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | February 25, 2025 | 8.49 |
Lowest Price | January 15, 2025 | 4.82 |
Enanta Pharmaceuticals March 22, 2025 Stock Price Synopsis
Various analyses of Enanta Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Enanta Stock. It can be used to describe the percentage change in the price of Enanta Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Enanta Stock.Enanta Pharmaceuticals Price Rate Of Daily Change | 0.98 | |
Enanta Pharmaceuticals Price Action Indicator | (0.11) | |
Enanta Pharmaceuticals Price Daily Balance Of Power | (0.46) |
Enanta Pharmaceuticals March 22, 2025 Stock Price Analysis
Enanta Stock Price History Data
The price series of Enanta Pharmaceuticals for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 has a statistical range of 3.67 with a coefficient of variation of 17.94. Under current investment horizon, the daily prices are spread out with arithmetic mean of 6.2. The median price for the last 90 days is 6.0.Open | High | Low | Close | Volume | ||
03/22/2025 | 6.34 | 6.49 | 6.21 | 6.31 | ||
03/21/2025 | 6.34 | 6.49 | 6.21 | 6.31 | 309,607 | |
03/20/2025 | 6.40 | 6.54 | 6.24 | 6.44 | 102,322 | |
03/19/2025 | 6.34 | 6.47 | 6.11 | 6.44 | 154,605 | |
03/18/2025 | 5.97 | 6.32 | 5.93 | 6.30 | 278,245 | |
03/17/2025 | 6.60 | 6.76 | 6.07 | 6.10 | 407,538 | |
03/14/2025 | 6.87 | 7.03 | 6.64 | 6.65 | 344,775 | |
03/13/2025 | 7.26 | 7.30 | 6.81 | 6.83 | 246,812 | |
03/12/2025 | 7.29 | 7.43 | 7.06 | 7.27 | 149,036 | |
03/11/2025 | 6.91 | 7.38 | 6.40 | 7.23 | 362,507 | |
03/10/2025 | 7.14 | 7.38 | 6.63 | 6.77 | 284,465 | |
03/07/2025 | 7.14 | 7.30 | 6.92 | 7.22 | 166,264 | |
03/06/2025 | 6.98 | 7.39 | 6.95 | 7.18 | 332,697 | |
03/05/2025 | 7.26 | 7.49 | 7.00 | 7.10 | 329,214 | |
03/04/2025 | 7.28 | 7.35 | 7.07 | 7.24 | 235,308 | |
03/03/2025 | 7.82 | 7.91 | 7.29 | 7.33 | 196,859 | |
02/28/2025 | 7.87 | 7.89 | 7.35 | 7.78 | 200,595 | |
02/27/2025 | 8.03 | 8.33 | 7.87 | 7.88 | 406,826 | |
02/26/2025 | 8.50 | 8.64 | 7.96 | 8.09 | 377,139 | |
02/25/2025 | 8.24 | 8.59 | 7.97 | 8.49 | 539,844 | |
02/24/2025 | 7.95 | 8.76 | 7.81 | 8.34 | 605,380 | |
02/21/2025 | 8.45 | 8.63 | 8.01 | 8.03 | 611,085 | |
02/20/2025 | 8.14 | 8.76 | 7.73 | 8.38 | 653,440 | |
02/19/2025 | 7.36 | 8.55 | 7.36 | 8.30 | 849,775 | |
02/18/2025 | 7.14 | 7.59 | 6.92 | 7.49 | 531,105 | |
02/14/2025 | 7.50 | 7.68 | 7.08 | 7.14 | 419,302 | |
02/13/2025 | 6.16 | 7.93 | 6.16 | 7.50 | 2,001,304 | |
02/12/2025 | 5.45 | 5.93 | 5.27 | 5.86 | 387,564 | |
02/11/2025 | 5.25 | 5.99 | 5.23 | 5.59 | 1,169,815 | |
02/10/2025 | 4.82 | 4.95 | 4.73 | 4.90 | 277,463 | |
02/07/2025 | 5.01 | 5.02 | 4.81 | 4.90 | 425,426 | |
02/06/2025 | 5.09 | 5.12 | 4.88 | 4.96 | 381,739 | |
02/05/2025 | 5.12 | 5.28 | 4.98 | 5.07 | 333,638 | |
02/04/2025 | 5.16 | 5.18 | 4.98 | 5.12 | 368,297 | |
02/03/2025 | 5.10 | 5.29 | 4.94 | 5.17 | 317,231 | |
01/31/2025 | 5.09 | 5.31 | 5.04 | 5.11 | 177,346 | |
01/30/2025 | 5.00 | 5.21 | 4.98 | 5.14 | 190,449 | |
01/29/2025 | 5.09 | 5.15 | 4.94 | 4.98 | 208,801 | |
01/28/2025 | 5.23 | 5.35 | 5.10 | 5.12 | 249,585 | |
01/27/2025 | 5.50 | 5.76 | 5.26 | 5.30 | 280,922 | |
01/24/2025 | 5.52 | 5.72 | 5.43 | 5.53 | 317,144 | |
01/23/2025 | 5.17 | 5.55 | 5.07 | 5.54 | 326,181 | |
01/22/2025 | 5.12 | 5.22 | 4.96 | 5.18 | 486,587 | |
01/21/2025 | 5.30 | 5.33 | 5.02 | 5.12 | 441,082 | |
01/17/2025 | 4.87 | 5.31 | 4.83 | 5.25 | 694,434 | |
01/16/2025 | 4.80 | 5.06 | 4.71 | 4.85 | 699,666 | |
01/15/2025 | 4.91 | 5.08 | 4.79 | 4.82 | 675,517 | |
01/14/2025 | 5.05 | 5.09 | 4.84 | 4.84 | 623,206 | |
01/13/2025 | 4.96 | 5.16 | 4.87 | 5.03 | 859,457 | |
01/10/2025 | 5.01 | 5.19 | 4.87 | 5.09 | 1,080,469 | |
01/08/2025 | 5.39 | 5.39 | 5.11 | 5.16 | 721,034 | |
01/07/2025 | 5.53 | 5.68 | 5.38 | 5.39 | 653,988 | |
01/06/2025 | 5.65 | 5.73 | 5.44 | 5.57 | 993,709 | |
01/03/2025 | 5.61 | 5.68 | 5.45 | 5.58 | 385,964 | |
01/02/2025 | 5.80 | 6.10 | 5.51 | 5.59 | 818,966 | |
12/31/2024 | 6.00 | 6.06 | 5.30 | 5.75 | 2,763,133 | |
12/30/2024 | 5.93 | 6.04 | 5.83 | 5.85 | 1,078,223 | |
12/27/2024 | 5.96 | 6.17 | 5.91 | 6.01 | 328,292 | |
12/26/2024 | 6.00 | 6.13 | 5.87 | 6.00 | 388,518 | |
12/24/2024 | 6.08 | 6.20 | 5.73 | 6.10 | 241,835 | |
12/23/2024 | 6.28 | 6.45 | 6.11 | 6.37 | 361,280 |
About Enanta Pharmaceuticals Stock history
Enanta Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Enanta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Enanta Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Enanta Pharmaceuticals stock prices may prove useful in developing a viable investing in Enanta Pharmaceuticals
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts. Enanta Pharmaceutica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 155 people.
Enanta Pharmaceuticals Stock Technical Analysis
Enanta Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
All Next | Launch Module |
Enanta Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Enanta Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Enanta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Enanta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0275 | |||
Jensen Alpha | 0.0505 | |||
Total Risk Alpha | 0.5181 | |||
Sortino Ratio | 0.0516 | |||
Treynor Ratio | (0.13) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Enanta Stock analysis
When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |